메뉴 건너뛰기




Volumn 171, Issue 1, 2014, Pages

Refractory hypercalcaemia secondary to parathyroid carcinoma: Response to high-dose denosumab

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CALCIUM; CHROMOGRANIN; CINACALCET; DENOSUMAB; LOOP DIURETIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PAMIDRONIC ACID; PARATHYROID HORMONE; VITAMIN D; ZOLEDRONIC ACID;

EID: 84903516289     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0166     Document Type: Article
Times cited : (42)

References (13)
  • 5
    • 33845960106 scopus 로고    scopus 로고
    • Parathyroid cancer: Etiology, clinical presentation and treatment
    • Lumachi F, Stefano MM & Basso U. Parathyroid cancer: etiology, clinical presentation and treatment. Anticancer Research 2006 26 4803-4808.
    • (2006) Anticancer Research , vol.26 , pp. 4803-4808
    • Lumachi, F.1    Stefano, M.M.2    Basso, U.3
  • 6
    • 79952360832 scopus 로고    scopus 로고
    • Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study
    • doi:10.1016/S0140-6736(10)62344-6
    • Fizazi K, Carducci M, Smith M, Damiaõ R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 2011 377 813-822. (doi:10.1016/S0140- 6736(10)62344-6)
    • (2011) Lancet , vol.377 , pp. 813-822
    • Fizazi, K.1    Carducci, M.2    Smith, M.3    Damiaõ, R.4    Brown, J.5    Karsh, L.6    Milecki, P.7    Shore, N.8    Rader, M.9    Wang, H.10
  • 8
    • 84878547627 scopus 로고    scopus 로고
    • Resistant hypercalcaemia in metastatic parathyroid carcinoma
    • doi:10.5694/mja12.11243
    • Samantha EB, Alison MW, David TR & John AD. Resistant hypercalcaemia in metastatic parathyroid carcinoma. Medical Journal of Australia 2013 198 559-561. (doi:10.5694/mja12.11243)
    • (2013) Medical Journal of Australia , vol.198 , pp. 559-561
    • Samantha, E.B.1    Alison, M.W.2    David, T.R.3    John, A.D.4
  • 9
    • 84903549034 scopus 로고    scopus 로고
    • updated 11th September 2013
    • Lawrence Kim, Parathyroid carcinoma. Medscape 2013. updated 11th September 2013. http://emedicine.medscape.com/article/280908-overview
    • (2013) Parathyroid Carcinoma
    • Kim, L.1
  • 10
    • 0033616471 scopus 로고    scopus 로고
    • Control of hypercalcaemia of parathyroid carcinoma by immunization
    • doi:10.1016/S0140-6736(98)06469-1
    • Bradwell AR & Harvey TC. Control of hypercalcaemia of parathyroid carcinoma by immunization. Lancet 1999 353 370-373. (doi:10.1016/S0140-6736(98) 06469-1)
    • (1999) Lancet , vol.353 , pp. 370-373
    • Bradwell, A.R.1    Harvey, T.C.2
  • 11
    • 84903540947 scopus 로고    scopus 로고
    • National Cancer Institute. updated 7th February 2013
    • FDA approval for denosumab. National Cancer Institute 2013. updated 7th February 2013. www.cancer.gov/cancertopics/druginfo/fdadenosumab
    • (2013) FDA Approval for Denosumab
  • 12
    • 84867606008 scopus 로고    scopus 로고
    • Denosumab in the treatment of bisphosphonate-refractory hypercalcaemia
    • doi:10.1200/JCO.2012.41.7923
    • Boikos SA & Hammers HJ. Denosumab in the treatment of bisphosphonate-refractory hypercalcaemia. Journal of Clinical Oncology 2012 30 e299. (doi:10.1200/JCO.2012.41.7923)
    • (2012) Journal of Clinical Oncology , vol.30
    • Boikos, S.A.1    Hammers, H.J.2
  • 13
    • 79952761418 scopus 로고    scopus 로고
    • Randomized, double-blind study of denosumab vs zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
    • doi:10.1200/JCO.2010.313304
    • Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S et al. Randomized, double-blind study of denosumab vs zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. Journal of Clinical Oncology 2011 29 1125-1132. (doi:10.1200/JCO.2010. 31.3304)
    • (2011) Journal of Clinical Oncology , vol.29 , pp. 1125-1132
    • Henry, D.H.1    Costa, L.2    Goldwasser, F.3    Hirsh, V.4    Hungria, V.5    Prausova, J.6    Scagliotti, G.V.7    Sleeboom, H.8    Spencer, A.9    Vadhan-Raj, S.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.